Skip to main content

Table 10 Assay results for the determination of VPS in laboratory prepared mixture with SFV at their pharmaceutical ratio by Method 1

From: Two novel UPLC methods utilizing two different analytical columns and different detection approaches for the simultaneous analysis of velpatasvir and sofosbuvir: application to their co-formulated tablet

Combination

Proposed method

Comparison method [11]

Amount taken (ng/mL)

Amount found (ng/mL)

% Found

% Found

Column (A)

Column (B)

Column (A)

Column (B)

Column (A)

Column (B)

VPS

SFV/VPS mixture 4:1 (w/w)

1.0

2.5

0.989

2.495

98.93

99.78

101.45

2.0

3.5

1.899

3.412

94.99

97.50

100.47

3.0

5.0

2.947

4.913

98.22

98.26

99.12

4.0

7.5

3.933

7.356

98.34

98.09

 

5.0

10.0

5.003

9.996

100.07

99.96

 

Mean

    

98.11

98.72

100.35

± SD

    

1.89

1.09

1.17

t-test

    

− 1.82

1.99

(2.45)*

F-test

    

2.62 (19.24)*

1.15 (6.94)*

 
  1. Each result is the average of three separate determinations
  2. * The figures between parentheses are the tabulated t and F values at P = 0.05 [17]